Lu B - Search Results

1

Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.

Haram KM, Peltier HJ, Lu B, Bhasin M, Otu HH, Choy B, Regan M, Libermann TA, Latham GJ, Sanda MG, Arredouani MS. Haram KM, et al. Among authors: lu b. Prostate. 2008 Oct 1;68(14):1517-30. doi: 10.1002/pros.20803. Prostate. 2008. PMID: 18668517

2

Identification of the transcription factor single-minded homologue 2 as a potential biomarker and immunotherapy target in prostate cancer.

Arredouani MS, Lu B, Bhasin M, Eljanne M, Yue W, Mosquera JM, Bubley GJ, Li V, Rubin MA, Libermann TA, Sanda MG. Arredouani MS, et al. Among authors: lu b. Clin Cancer Res. 2009 Sep 15;15(18):5794-802. doi: 10.1158/1078-0432.CCR-09-0911. Epub 2009 Sep 8. Clin Cancer Res. 2009. PMID: 19737960 Free PMC article.

3

The role of the transcription factor SIM2 in prostate cancer.

Lu B, Asara JM, Sanda MG, Arredouani MS. Lu B, et al. PLoS One. 2011;6(12):e28837. doi: 10.1371/journal.pone.0028837. Epub 2011 Dec 9. PLoS One. 2011. PMID: 22174909 Free PMC article.

4

Fas-mediated T cell deletion potentiates tumor antigen-specific tolerance in a mouse model of prostate cancer.

Tseng-Rogenski SS, Arredouani MS, Neeley YC, Lu B, Chinnaiyan AM, Sanda MG. Tseng-Rogenski SS, et al. Among authors: lu b. Cancer Immunol Immunother. 2008 Sep;57(9):1357-65. doi: 10.1007/s00262-008-0471-z. Epub 2008 Feb 12. Cancer Immunol Immunother. 2008. PMID: 18265979 Free PMC article.

5

Detection of TMPRSS2-ERG fusion gene expression in prostate cancer specimens by a novel assay using branched DNA.

Lu B, Maqsodi B, Yang W, McMaster GK, Perner S, Regan M, Bubley GJ, Balk SP, Rubin M, Sanda MG. Lu B, et al. Urology. 2009 Nov;74(5):1156-61. doi: 10.1016/j.urology.2009.01.087. Epub 2009 Aug 3. Urology. 2009. PMID: 19647299 Free PMC article.

6

[Differential expressions of the receptor for advanced glycation end products in prostate cancer and normal prostate].

Lu B, Song XL, Jia LY, Song FL, Zhao SC, Jiang Y. Lu B, et al. Zhonghua Nan Ke Xue. 2010 May;16(5):405-9. Zhonghua Nan Ke Xue. 2010. PMID: 20684319 Chinese.

7

[Construction of eukaryotic expression vectors for different domains of the extracellular region of RAGE and their expression in prostate cancer cells].

Li J, Song X, Lu B, Li Y, Hong Y, Deng P, Zhao C, Luo H, Zhao S, Jiang Y. Li J, et al. Among authors: lu b. Nan Fang Yi Ke Da Xue Xue Bao. 2012 Apr;32(4):507-10. Nan Fang Yi Ke Da Xue Xue Bao. 2012. PMID: 22543131 Chinese.

8

[Construction, expression and location of eukaryotic expression vector CMV-FLAG-RB in human prostate cancer PC-3 cells].

Lu B, Song XL, Song FL, Zhao SC, Jiang Y. Lu B, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2010 Mar;30(3):422-5. Nan Fang Yi Ke Da Xue Xue Bao. 2010. PMID: 20335100 Chinese.

9

[A meta-analysis of holmium laser enucleation of the prostate for benign prostatic hyperplasia].

Zhao CB, Li JC, Yuan PQ, Hong YQ, Lu B, Zhao SC. Zhao CB, et al. Among authors: lu b. Zhonghua Nan Ke Xue. 2011 Dec;17(12):1112-20. Zhonghua Nan Ke Xue. 2011. PMID: 22235682 Chinese.

10

Decoy-resistant IL-18 reshapes the tumor microenvironment and enhances rejection by anti-CTLA-4 in renal cell carcinoma.

Schoenfeld DA, Djureinovic D, Su DG, Zhang L, Lu BY, Kamga L, Mann JE, Huck JD, Hurwitz M, Braun DA, Jilaveanu L, Ring AM, Kluger HM. Schoenfeld DA, et al. Among authors: lu by. JCI Insight. 2024 Nov 19:e184545. doi: 10.1172/jci.insight.184545. Online ahead of print. JCI Insight. 2024. PMID: 39561007

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,022 results

Search Page

Filters